Pettinga Financial Advisors Portfolio Changes: Significant Buys & Sells in Q2
Pettinga Financial Advisors' portfolio saw notable shifts this quarter with substantial increases in holdings like GOVT and IWF alongside decreases in QUAL and EFV.

As of June 30, 2026, Pettinga Financial Advisors LLC has reported changes to its investment portfolio. The firm's holdings reflect active management decisions across various asset classes.
Prominent Purchases This Quarter
Pettinga Financial Advisors demonstrated significant buying activity during this period, adding substantial weight to several core holdings within their $554 million portfolio. Notably, the firm increased its stake in GOVT by a staggering 208.86%, representing one of the largest share increases seen.
- IWF: The firm boosted its position in ISHARES TR (IWF) by 318.34%, indicating strong confidence in this emerging markets-focused fund.
- BNDX: Holdings in the Vanguard fund VANGUARD CHARLOTTE FDS (BNDX) increased by 102.85%, suggesting a diversification effort into fixed income solutions.
- RBB Fund Trust: The ETF RBB FUND TRUST (75526L886) saw a 266.02% jump in shares, highlighting the firm's interest in this specific fund.
In addition to these large allocations shifts, Pettinga also initiated new positions or increased existing ones with smaller but still noteworthy transactions:
- ABRDN Platinum ETF Trust: The investor added shares of PPLT, an ETF focused on precious metals, allocating 0.12% to this sector.
- Cohen & Steers Select Preferred: Holdings in the preferred fund PSF increased by a significant margin, with shares growing 101.16%.
- Cohen & Steers Tax Advantaged Preferred: The firm also bolstered its position in the tax-advantaged preferred fund PTA by 61.01%.
- ISHARES TR (MBB): The emerging markets bond ETF MBB received a notable increase, growing the investor's allocation to 1.47%.
- ISHARES TR (IVE): Despite being listed in top holdings by weight earlier, IVE saw a substantial share increase of -18.44% from the prior period? Wait no, looking at data: IVE's change_percent_from_prior_period is negative (-18.44%), so it was actually sold.
The firm also continued to build its exposure in other areas:
- ISHARES TR (QUAL): The quality-focused ETF QUAL experienced a significant decrease of -50.71%.
- ISHARES TR (EFV): The emerging markets value fund EFV saw a sharp decline of -77.56%.
- XBI: Holdings in the biotech ETF XBI decreased by 20.69%, though it wasn't listed as a significant sell symbol, just a reduction mentioned generally.
- ISHARES TR (QUAL): As noted above, this technology-focused fund QUAL was sold significantly (-50.71%).
- XLP: The consumer staples ETF XLP decreased by 20.69%.
- XLV: The healthcare ETF XLV saw a decrease of -50.71%, though it wasn't listed as a significant sell symbol, just a reduction mentioned generally.
- AAPL: The firm's stake in Apple Inc. (AAPL) remained relatively stable at 2.29%, with a small decrease of -1.08%.
- IVW: The small-cap value ETF IVW saw a modest reduction (-2.75%).
Notable Sales and Reductions This Quarter
Pettinga Financial Advisors also showed decisive selling activity during this quarter, reducing positions in several ETFs:
The firm also made adjustments to other holdings:
Overall Portfolio Changes and Activity
Pettinga Financial Advisors managed 149 holdings during this quarter, with their largest positions accounting for approximately $638 million in ISHARES TR (IVV), though the ETF saw a slight increase of +45.54%.
The portfolio's sector allocation remains dominated by 'Unknown' at 87.81%, followed closely by Financial Services (4.99%) and Technology (3.81%). No other sectors showed substantial changes this quarter.